For decades, pharmaceutical companies have built commercial strategies around human influence: reps educating doctors; marketers crafting brand narratives and payers evaluating dossiers. But that model is being quietly disrupted.
AI has become the gatekeeper between your brand and your buyer, becoming the first and most influential evaluator of your product’s value.
While the industry debates AI pilots and compliance parameters, intelligent agents are already shaping what healthcare professionals (HCPs) see, the information they trust and which brands rise to the top.
Check out the rest of the feature here
